fake ivermectin studies – The Burning Platform

Guest Post by Doctor Pierre Kory

The New England Journal of Medicine recently published the fraudulent TOGETHER trial, designed and conducted to launch anti-ivermectin headlines across every major media outlet across the world.

The Global Disinformation Campaign Against Ivermectin Series:

Part I – Introduction to the Disinformation Playbook

Part II – Exposing the Corrupt Disinformation Campaign on Ivermectin

Part II – Ivermectin – An Attack by New York State’s Attorney General

Part III – Ivermectin – Lawyers Helping Doctors be Doctors

Part IV – Ivermectin – Saturday Night Fight At The Pharmacy

Part IV – Ivermectin – JAMA’s “Diversion Tactic “- the HITECH Trial

Part VII – Op-Ed on Fluvoxamine

Part VIII – Op-Ed on Remdesivir

Part IX – Ivermectin – “The Fix“ of Andrew Hill – Chapter 1

Part X -Ivermectin – “The Fix” of Andrew Hill – Chapter 2

Part XI- Big Pharma’s “Diversion” – The TOGETHER Trial Published in the New England Journal of Medicine

native advertising

Big Pharma (Pfizer and BMGF from what it looks to me) dropped another nuclear bomb on ivermectin 3 weeks ago with their successful publication of the fraudulent Brazilian TOGETHER trial. They did it in one of the world’s top read and rated medical journals, the New England Journal of Medicine (NEJM), a journal born in the year 1812, but captured by Pharma for who knows how long now. This is an open secret as per former Editor Marcia Angell in the book Drug Companies & Doctors: A Story of Corruption:

“It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine.” –Dr. Marcia Angell.

Continue reading “Fraudulent Trial On Ivermectin Published By The World’s Top Medical Journal. Big Pharma Reigns – Part I”

Guest Post by Madhava Setty, M.D.

The New York Times on Wednesday sent an email to subscribers titled: “Breaking News: Ivermectin failed as a Covid treatment . . .” The Times was referring to a study in the New England Journal of Medicine, covered March 18 by The Wall Street Journal. In both cases, the newspapers failed to provide an accurate critical analysis of the study.

The New York Times on Wednesday sent an email blast to subscribers with the subject line: “Breaking News: Ivermectin failed as a Covid treatment, a large clinical trial found.”

The Times was referring to a study I wrote about, that same day, for The Defender.

My article called out the Wall Street Journal for its March 18 reporting on the same study — before the study was even published — for its failure to provide an accurate, critical assessment of the study.

The study in question — “Effect of Early Treatment with Ivermectin among Patients with Covid-19” — was officially published Wednesday in the New England Journal of Medicine (NEJM).

In it the authors concluded:

“Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to progression of Covid-19 or of prolonged emergency department observation among outpatients with an early diagnosis of Covid-19”

Continue reading “NY Times Latest to Mislead Public on New Ivermectin Study”